Cargando…
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes
[Image: see text] Magnetic resonance imaging (MRI) is one of the most sophisticated diagnostic tools that is routinely used in clinical practice. Contrast agents (CAs) are commonly exploited to afford much clearer images of detectable organs and to reduce the risk of misdiagnosis caused by limited M...
Autores principales: | Tullio, Chiara, Salvioni, Lucia, Bellini, Michela, Degrassi, Anna, Fiandra, Luisa, D’Arienzo, Massimiliano, Garbujo, Stefania, Rotem, Rany, Testa, Filippo, Prosperi, Davide, Colombo, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596607/ https://www.ncbi.nlm.nih.gov/pubmed/34805780 http://dx.doi.org/10.1021/acsabm.1c00724 |
Ejemplares similares
-
The Role of Polymeric Coatings for a Safe-by-Design Development of Biomedical Gold Nanoparticles Assessed in Zebrafish Embryo
por: Floris, Pamela, et al.
Publicado: (2021) -
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts
por: Del Nero, Martina, et al.
Publicado: (2023) -
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection
por: Salvioni, Lucia, et al.
Publicado: (2022) -
Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009) -
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies
por: Colombo, Miriam, et al.
Publicado: (2016)